Continuing Medical Education Information
Accreditation and Designation Statement
The American Society of Clinical Oncology (ASCO) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
ASCO designates this live activity for a maximum of 24.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Needs Statement
To date, few educational opportunities address the need for the diagnosis, treatment, and management of patients with gastrointestinal cancers in a multidisciplinary forum. Physicians and other medical professionals involved with cancer care and research call for access to advances in research and treatment of patients with gastrointestinal cancers in order to provide quality care to patients and improve outcomes. The 2012 Gastrointestinal Cancers Symposium provides a forum for the assessment and increase of competency in the research and treatment developments for gastrointestinal cancers.
Target Audience
This Symposium is designed for physicians and researchers interested in the prevention, screening, evaluation, and management of gastrointestinal cancers, including medical, surgical and radiation oncologists; radiologists; gastroenterologists; pathologists; and translational-oriented laboratory scientists.
This Symposium may also be of benefit to nurses, pharmacists, physician assistants, and other health care professionals involved in clinical care and research in this area.
Learning Objectives
Upon participation in this activity, attendees will be able to
- Identify the most promising molecular pathways to develop new agents for therapy and drug delivery for patients with gastrointestinal cancer
- Compare and contrast current and emerging imaging techniques and screening modules used for the prevention, screening, and diagnosis of gastrointestinal cancers
- Evaluate and recommend multidisciplinary treatment plans based on both effectiveness and appropriateness for patients with gastrointestinal cancers
- Include strategies for supportive care and survivorship in management plans, and be able to counsel patients in areas of particular concern related to maintaining quality of life
- Analyze results from key U.S. and international cooperative group trials attempting to define standard-of-care treatments for patients with gastrointestinal cancers
This activity was planned in the context of the following ACGME competencies: Patient Care, Medical Knowledge, Practiced-based Learning and Improvement, Professionalism, and Systems-based Practice.
Disclaimer and Unlabeled Usage Statement
The information presented is that of the contributing faculty and does not necessarily represent the views of the American Gastroenterological Association (AGA) Institute, the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO) or the Society of Surgical Oncology (SSO), and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information including indications, contraindications, warnings, precautions, and adverse effects.